Latest Financial Management News

Cann Group Limited delivered record production and revenue growth in Q4 FY2025, securing new funding and advancing a major debt restructuring to set the stage for profitability in FY2026.

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Activeport Group Ltd reported a strong Q4 FY25 with significant revenue growth in software and Network as a Service segments, underpinned by new contracts with leading telecom providers and improved cash flow management.

ClearVue Technologies has announced a major leadership overhaul alongside strategic partnerships and market expansion, highlighted by a solar façade trial in Hong Kong demonstrating a payback period as low as 2.6 years.

Hawk Resources has identified six new copper soil anomalies aligned with geophysical targets at its Cactus project in Utah, alongside a significant 1.1km gold soil anomaly extending from the historic Cactus mine. The company also launched US OTC trading and updated its Brazilian lithium tenement portfolio.

Airtasker Limited has reported its second consecutive year of positive free cash flow alongside robust revenue growth, fueling accelerated expansion in the UK and US marketplaces.

Core Energy Minerals has initiated its first aircore drilling program at the Cummins Uranium Project in South Australia, while confirming uranium mineralisation in Brazil and refinancing its convertible notes to support ongoing exploration.

Electro Optic Systems (EOS) has secured its largest-ever order for the Slinger Counter-Drone system, boosting its contract backlog by 25% to $170 million and reporting strong cash flow and a debt-free balance sheet.

Oakajee Corporation has progressed its gold exploration efforts at the Paynes Find project in Western Australia, preparing for drilling in the September quarter while maintaining a solid financial position.

Fluence Corporation Limited reported a positive net operating cash flow of US$5.1 million for Q2 2025, boosting its cash reserves to US$12.7 million and maintaining solid liquidity through revolving credit and loan facilities.

Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.

Indiana Resources has reported significant extensions of high-grade gold mineralisation at its Minos prospect within the Gawler Craton Project, alongside a proposed capital return and key executive appointments to drive future growth.